---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-043095"
form_type: "8-K"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2023-04-07T23:59:59+00:00"
generated_at: "2026-06-17T04:34:13.965822+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Leap Therapeutics amends CMO's severance; boosts benefits post-change-in-control

## Summary
- CMO Cynthia Sirard gets 100% base salary severance (12 monthly installments) on non-Cause termination or Good Reason resignation.
- Post-change-in-control termination within 1 year: severance increases to 125% base salary (lump sum) and COBRA reimbursed for 15 months (lump sum).
- Equity awards become exercisable for up to 2 years after qualifying termination following a change in control.

## SEC filing metadata
- accession: 0001104659-23-043095
- form_type: 8-K
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2023-04-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000110465923043095/0001104659-23-043095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000110465923043095/tm2312108d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-043095
- JSON: https://secwatch.observer/filing/0001104659-23-043095.json
- Plain text: https://secwatch.observer/filing/0001104659-23-043095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.